Cardio Diagnostics Inc.

NASDAQ: CDIO · Real-Time Price · USD
3.64
-0.38 (-9.52%)
At close: Aug 15, 2025, 3:59 PM
3.66
0.55%
After-hours: Aug 15, 2025, 04:04 PM EDT

Cardio Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
34.89K 17.07K 950.00 901.00
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
34.89K 17.07K -15.05K 901.00
Operating Income
-8.37M -7.24M -4.55M -620.45K
Interest Income
1.06K 1.07K n/a n/a
Pretax Income
-8.38M -8.38M -4.66M -620.45K
Net Income
-8.38M -8.38M -4.66M -620.45K
Selling & General & Admin
8.35M 7.09M 4.49M 573.88K
Research & Development
29.13K 145.18K 40.45K 31.47K
Other Expenses
19.74K 19.18K 16K 16K
Operating Expenses
8.4M 7.26M 4.55M 621.35K
Interest Expense
18.64K 6.74M n/a n/a
Selling & Marketing Expenses
182.45K 158.51K 92.7K 103.32K
Cost & Expenses
8.4M 7.26M 4.55M 621.35K
Income Tax Expense
n/a n/a n/a 2.00
Shares Outstanding (Basic)
26.89M 422.84K 3.09M 317.16K
Shares Outstanding (Diluted)
26.89M 422.84K 3.09M 317.16K
EPS (Basic)
-9.3 -19.8 -45.3 -1.96
EPS (Diluted)
-9.3 -19.8 -45.3 -1.96
EBITDA
-8.09M -1.53M -4.64M -604.45K
EBIT
-8.37M -1.64M -4.66M -620.45K
Depreciation & Amortization
276.35K 111.62K 16K 16K